ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference
ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference
SAN DIEGO, Dec. 30, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference on Thursday, January 6, 2022, beginning at approximately 4:00 p.m. (Eastern Standard Time).
聖迭戈，2021年12月30日(環球通訊社)--ResMed(紐約證券交易所代碼：RMD，ASX：RMD)今天宣佈，首席執行官米克·法雷爾(Mick Farrell)將出席高盛14年度醫療保健CEO無腳本會議將於2022年1月6日(星期四)下午4：00左右開始。(東部標準時間)。
More information about this event, including a link to the live webcast, may be accessed by visiting . The webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible through January 6, 2023.
有關本次活動的更多信息，包括現場網絡直播的鏈接，可以通過訪問訪問。網絡直播重播將在網絡直播結束後大約24小時內播放，並將持續到2023年1月6日。
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
關於ResMed
在ResMed(紐約證券交易所股票代碼：RMD，ASX：RMD)，我們開創了創新的解決方案，治療並讓人們遠離醫院，使他們能夠過上更健康、更高質量的生活。我們的數字健康技術和雲連接醫療設備改變了對睡眠呼吸暫停、慢性阻塞性肺病和其他慢性病患者的護理。我們全面的院外軟件平臺支持專業人員和護理人員，他們幫助人們在自己選擇的家庭或護理環境中保持健康。通過提供更好的護理，我們提高了生活質量，降低了慢性病的影響，並降低了140多個國家的消費者和醫療保健系統的成本。要了解更多信息，請訪問ResMed.com並關注@ResMed。
| For investors | For media | ||
| Amy Wakeham | Jayme Rubenstein | ||
| +1 858.836.5000 | +1 858.836.6798 | ||
| investorrelations@resmed.com | news@resmed.com |
| 對於投資者來説 | 為媒體 | ||
| 艾米·韋克漢姆 | 傑米·魯賓斯坦(Jayme Rubenstein) | ||
| +1 858.836.5000 | +1 858.836.6798 | ||
| 郵箱：InvestorRelations@resmed.com | 郵箱：news@resmed.com |
譯文內容由第三人軟體翻譯。